Search research articles
Contact Us
Filters
Showing results (291-300 of 3,120) with videos related to
Page
of 312
Sort By:
Journal of Thrombosis and Thrombolysis
|
August 6, 2005
Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigm
Richard C Becker
The American Journal of Cardiology
|
January 3, 1992
Thrombin antagonists and antiplatelet agents
R C Becker
Journal of Thrombosis and Thrombolysis
|
February 6, 2007
Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
February 3, 2009
Thrombogenesis in atrial fibrillation contributing mechanisms and natural history
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
April 24, 2010
Examining biology and pharmacology-based hypotheses in the PLATO trial
Richard C Becker
Lancet (London, England)
|
May 5, 2009
The importance of VTE prevention after orthopaedic surgery
Richard C Becker
Cardiovascular Drugs and Therapy
|
October 1, 1991
Do neutrophils contribute to myocardial stunning?
L C Becker
Journal of Thrombosis and Thrombolysis
|
September 4, 2020
Anticipating the long-term cardiovascular effects of COVID-19
Richard C Becker
Anesthesiology
|
March 1, 1987
Is isoflurane dangerous for the patient with coronary artery disease?
L C Becker
Journal of Thrombosis and Thrombolysis
|
April 13, 2023
Evaluating chest pain in patients with post COVID conditions permission to think outside of the box
Richard C Becker
Page
of 312
Search research articles
Search
Showing results (291-300 of 3,120) with videos related to
Sort By:
Page
of 312
Journal of Thrombosis and Thrombolysis
|
August 6, 2005
Patient-specific antithrombotic strategies: lessons not yet learned from the renal insufficiency paradigm
Richard C Becker
The American Journal of Cardiology
|
January 3, 1992
Thrombin antagonists and antiplatelet agents
R C Becker
Journal of Thrombosis and Thrombolysis
|
February 6, 2007
Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
February 3, 2009
Thrombogenesis in atrial fibrillation contributing mechanisms and natural history
Richard C Becker
Journal of Thrombosis and Thrombolysis
|
April 24, 2010
Examining biology and pharmacology-based hypotheses in the PLATO trial
Richard C Becker
Lancet (London, England)
|
May 5, 2009
The importance of VTE prevention after orthopaedic surgery
Richard C Becker
Cardiovascular Drugs and Therapy
|
October 1, 1991
Do neutrophils contribute to myocardial stunning?
L C Becker
Journal of Thrombosis and Thrombolysis
|
September 4, 2020
Anticipating the long-term cardiovascular effects of COVID-19
Richard C Becker
Anesthesiology
|
March 1, 1987
Is isoflurane dangerous for the patient with coronary artery disease?
L C Becker
Journal of Thrombosis and Thrombolysis
|
April 13, 2023
Evaluating chest pain in patients with post COVID conditions permission to think outside of the box
Richard C Becker
Page
of 312